A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/40 (2006.01) A61K 31/395 (2006.01) A61K 31/407 (2006.01)
Patent
CA 2257693
A method for treating endothelial cell dysfunction, such as associated with cardiovascular disease are disclosed, particularly using the isozyme selective PKC inhibitor, (S)-3,4-[N,N'-1,1'-((27''-ethoxy)-3'''(O)-4'''-(N,N- dimethylamino)-butane)-bis-(3,3'indolyl)]-1(H)-pyrrole-2,5-dione hydrochloride salt.
Cette invention se rapporte à un procédé de traitement des dysfonctionnements des cellules endothéliales, tels que ceux associés aux maladies cardio-vasculaires, et notamment à l'utilisation de l'inhibiteur de protéine kinase C (PKC) sélectif vis-à-vis des iso-enzymes qu'est l'hydrochlorate de (S)-3,4-[N,N'-1,1'-((27''éthoxy)-3'''(O)-4'''-(N,N-diméthylamino)-butane)-bis-(3,3'-indolyl)]-1(H)-pyrrole-2,5-dione.
Heath William Francis Jr.
Jirousek Michael R.
Stramm Lawrence E.
Ways Douglas Kirk
Eli Lilly And Company
Gowling Lafleur Henderson Llp
LandOfFree
Therapeutic treatment for cardiovascular diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Therapeutic treatment for cardiovascular diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Therapeutic treatment for cardiovascular diseases will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1549908